Martins Otun Receives Global Award in Artificial Intelligence and Pharmaceutical Technology

Martins Otun, founder and chief scientist of Scotland-based Algonix AI, has won the 2026 Global Recognition Award for his innovative work in artificial intelligence and pharmacy.

Martins Otun, founder and chief scientist of the Scotland-based company Algonix AI, won the 2026 Global Recognition Award for his achievements in technology innovation, artificial intelligence, and pharmaceutical research. Otun stood out for his leadership in increasing the accessibility of advanced scientific research by transitioning from clinical pharmacy to artificial intelligence.

Biologix AI, the main platform behind the award, aims to discover and evaluate materials that will ensure life-saving drugs remain stable without the need for a cold chain. Especially in regions experiencing power outages or where refrigeration facilities are limited, the transportation and storage of critical medications such as insulin, vaccines, and therapeutic antibodies create significant costs and challenges. Biologix aims to help researchers find new materials to counter these temperature-induced degradation problems.

According to developments announced by Algonix AI on November 11, 2026, the platform has already achieved promising computational research results in material discoveries for insulin applications. These developments continue to attract the attention of international research circles.